Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2020 Jan 13;29(4):104561. doi: 10.1016/j.jstrokecerebrovasdis.2019.104561

Table 1.

Patient demographics, clinical variables, and PHQ-9 scores.

Patient Demographics N=201
Age, mean ± SD 61.82 ± 14.84
Male sex 116 (58%)
Race
Non-Hispanic White 94 (47%)
Non-Hispanic Black 56 (28%)
Hispanic 35 (17%)
Asian 4 (2%)
Unknown 12 (6%)
Marital Status
Single 40 (20%)
Married 116 (58%)
Divorced 14 (7%)
Widowed 21 (10%)
Unknown 10 (5%)
Employment Status
Employed 65 (32%)
Unemployed 11 (6%)
Retired 59 (29%)
Disabled 14 (7%)
Unknown 52 (26%)
Stroke Circulation Location
Anterior 119 (59%)
Posterior 70 (35%)
Both Anterior and Posterior 12 (6%)
Stroke Side
Right 94 (47%)
Left 92 (46%)
Bilateral 15 (7%)
NIHSS * on Hospital Admission
Mild (0–4) 117 (58%)
Moderate (5–15) 70 (35%)
Severe (≥16) 13 (6.5%)
unknown 1 (0.5%)
mRS at Clinic Follow-Up
0–1 96 (48%)
≥2 103 (52%)
Antidepressants
On Antidepressant at Admission 21 (10%)
Prescribed Antidepressant at Discharge 18 (9%)
Continued Antidepressant at Discharge 20 (10%)
On Antidepressant at Follow up 42 (21%)
Prescribed Antidepressant at Follow-Up 36 (18%)
Depressive Symptoms by Admission PHQ-9 Score
None (Score 0–4) 141 (70%)
Mild (Score 5–9) 43 (21%)
Moderate (Score 10–14) 15 (8%)
Moderately Severe to Severe (Score 15–27) 2 (1%)
Depressive Symptoms by Follow-Up PHQ-9 Score
None (Score 0–4) 109 (54%)
Mild (Score 5–9) 46 (23%)
Moderate (Score 10–14) 27 (13%)
Moderately Severe to Severe (Score 15–27) 19 (10%)
PHQ-9 Score Change on Clinic Follow-Up
Stable or Improved 128 (64%)
Worse 73 (36%)
*

National Institutes of Health Stroke Scale

modified Rankin Scale

Patient Health Questionnaire-9